Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kenneth Galbraith

Premium

Tekmira Pharmaceuticals disclosed that board member Kenneth Galbraith has resigned from the company.

Tekmira said that, to its knowledge, the departure was "not the result of any disagreement with the corporation relating to [its] operations, policies, or practices."

Galbraith joined Tekmira's board of directors in January 2010. He is currently a general partner at Ventures West, handling that firm's biotechnology practice.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.